These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37367811)

  • 1. Conformational State of Fenamates at the Membrane Interface: A MAS NOESY Study.
    Khodov IA; Belov KV; Huster D; Scheidt HA
    Membranes (Basel); 2023 Jun; 13(6):. PubMed ID: 37367811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raman and IR spectroscopic studies of fenamates--conformational differences in polymorphs of flufenamic acid, mefenamic acid and tolfenamic acid.
    Jabeen S; Dines TJ; Leharne SA; Chowdhry BZ
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():972-85. PubMed ID: 22954807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenamates inhibit human sodium channel Nav1.7 and Nav1.8.
    Sun JF; Xu YJ; Kong XH; Su Y; Wang ZY
    Neurosci Lett; 2019 Mar; 696():67-73. PubMed ID: 30528877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates.
    Khalifah RG; Hignite CE; Pentikäinen PJ; Penttilä A; Neuvonen PJ
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):269-76. PubMed ID: 7166179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of fenamates on Ca-activated chloride and potassium currents in rabbit portal vein smooth muscle cells.
    Greenwood IA; Large WA
    Br J Pharmacol; 1995 Dec; 116(7):2939-48. PubMed ID: 8680728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates.
    Kankaanranta H; Moilanen E; Vapaatalo H
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):685-91. PubMed ID: 7708126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenamates as Potential Therapeutics for Neurodegenerative Disorders.
    Hill J; Zawia NH
    Cells; 2021 Mar; 10(3):. PubMed ID: 33809987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple actions of fenamates and other nonsteroidal anti-inflammatory drugs on GABA
    Mansikkamäki S; Sinkkonen ST; Korpi ER; Lüddens H
    Eur J Pharmacol; 2019 Jun; 853():247-255. PubMed ID: 30930251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infrared studies of the polymorphic states of the fenamates.
    Gilpin RK; Zhou W
    J Pharm Biomed Anal; 2005 Mar; 37(3):509-15. PubMed ID: 15740911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological control of human polymorphonuclear leukocyte degranulation by fenamates and inhibitors of receptor-mediated calcium entry and protein kinase C.
    Kankaanranta H; Moilanen E; Lindberg K; Vapaatalo H
    Biochem Pharmacol; 1995 Jul; 50(2):197-203. PubMed ID: 7632163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane hydration and structure on a subnanometer scale as seen by high resolution solid state nuclear magnetic resonance: POPC and POPC/C12EO4 model membranes.
    Volke F; Pampel A
    Biophys J; 1995 May; 68(5):1960-5. PubMed ID: 7612838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental photochemistry of fenamate NSAIDs and their radical intermediates.
    Davis CA; Erickson PR; McNeill K; Janssen EML
    Environ Sci Process Impacts; 2017 May; 19(5):656-665. PubMed ID: 28401228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenamates as TRP channel blockers: mefenamic acid selectively blocks TRPM3.
    Klose C; Straub I; Riehle M; Ranta F; Krautwurst D; Ullrich S; Meyerhof W; Harteneck C
    Br J Pharmacol; 2011 Apr; 162(8):1757-69. PubMed ID: 21198543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenamates and the potent inhibition of human liver phenol sulphotransferase.
    Vietri M; De Santi C; Pietrabissa A; Mosca F; Pacifici GM
    Xenobiotica; 2000 Feb; 30(2):111-6. PubMed ID: 10718119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship of fenamates as Slo2.1 channel activators.
    Garg P; Sanguinetti MC
    Mol Pharmacol; 2012 Nov; 82(5):795-802. PubMed ID: 22851714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the conformational profiles of fenamates shows route towards novel, higher accuracy, force-fields for pharmaceuticals.
    Uzoh OG; Galek PT; Price SL
    Phys Chem Chem Phys; 2015 Mar; 17(12):7936-48. PubMed ID: 25720865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete relaxation and conformational exchange matrix (CORCEMA) analysis of NOESY spectra of interacting systems; two-dimensional transferred NOESY.
    Moseley HN; Curto EV; Krishna NR
    J Magn Reson B; 1995 Sep; 108(3):243-61. PubMed ID: 7670757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids.
    Neuvonen PJ; Kivistö KT
    Eur J Clin Pharmacol; 1988; 35(5):495-501. PubMed ID: 3266151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural studies of analgesics and their interactions. XII. Structure and interactions of anti-inflammatory fenamates. A concerted crystallographic and theoretical conformational study.
    Dhanaraj V; Vijayan M
    Acta Crystallogr B; 1988 Aug; 44 ( Pt 4)():406-12. PubMed ID: 3271554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenamates Inhibit Human Sodium Channel Nav1.2 and Protect Glutamate-Induced Injury in SH-SY5Y Cells.
    Sun JF; Zhao MY; Xu YJ; Su Y; Kong XH; Wang ZY
    Cell Mol Neurobiol; 2020 Nov; 40(8):1405-1416. PubMed ID: 32162200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.